Norway Considering National Biosample Company | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The government of Norway is considering forming a national company to commercialize biomaterials assets from the nation's collection of human samples and related information, Oslo-based Hunt Biosciences said today.

A government task force has suggested creating one company modeled on Hunt, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.